Jan 27, 2022 / 09:15PM GMT
Operator
Thank you for standing by. This is the conference operator. Welcome to Aridis Pharmaceuticals' investor update conference call. All participants are in a listen-only mode. The conference is being recorded. The call will be open for Q&A following management's presentation. On today's call are Aridis Pharmaceuticals' CEO, Vu Truong; and CFO, Fred Kurland.
Before we begin, I would like to remind everybody that this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, along with other statements about the future expectations, beliefs, goals, plans or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact should also be considered forward-looking statements, and forward-looking statements involve risks and uncertainties.
I would now like to turn the call over to Dr. Vu Truong, Aridis Pharmaceuticals' Chief Executive Officer. Dr. Truong, please go ahead.
Vu Truong -
Aridis Pharmaceuticals Inc Investor Update Call Transcript
Jan 28, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers